Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients
Three-year overall survival (OS) rates according to the preoperative serum interleukin-6 (IL-6) status (Kaplan-Meier analysis). (a) OS of all 233 patients. (b) OS of the 188 stages I–III colorectal cancer patients. (c) OS of the 45 stage IV patients.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.